MARKET

QURE

QURE

Uniqure
NASDAQ
27.87
+0.30
+1.09%
After Hours: 27.84 -0.03 -0.11% 16:55 06/15 EDT
OPEN
27.75
PREV CLOSE
27.57
HIGH
28.50
LOW
27.26
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
71.50
52 WEEK LOW
8.73
MARKET CAP
1.76B
P/E (TTM)
-7.9352
1D
5D
1M
3M
1Y
5Y
1D
Don't Ignore The Insider Selling In uniQure
Simply Wall St · 12h ago
Weekly Report: what happened at QURE last week (0608-0612)?
Weekly Report · 13h ago
UniQure Rocked by Wave of High-Level Insider Stock Sales
TipRanks · 2d ago
How Investors Are Reacting To uniQure (QURE) After FDA Rejects Accelerated Path For AMT-130
Simply Wall St · 5d ago
A Look At uniQure (QURE) Valuation After FDA Setback For Huntington’s Disease Therapy
Simply Wall St · 6d ago
Weekly Report: what happened at QURE last week (0601-0605)?
Weekly Report · 06/08 09:59
Acting FDA head vows to block political interference, Endpoint News says
TipRanks · 06/04 18:16
Watching uniQure; Shares See A Spike In Volume, Endpoints News Reports "Acting FDA Commissioner Pledges To Prevent Political Interference In Rare Disease Meeting"
Benzinga · 06/04 18:04
More
About QURE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.

Webull offers Uniqure NV stock information, including NASDAQ: QURE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QURE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QURE stock methods without spending real money on the virtual paper trading platform.